ACCELERATE DIAGNOSTICS INC's ticker is AXDX and the CUSIP is 00430H102. A total of 107 filers reported holding ACCELERATE DIAGNOSTICS INC in Q3 2021. The put-call ratio across all filers is 5.43 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $1,000 | -50.0% | 475 | 0.0% | 0.00% | – |
| Q4 2021 | $2,000 | -33.3% | 475 | 0.0% | 0.00% | -100.0% |
| Q3 2021 | $3,000 | -25.0% | 475 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $4,000 | 0.0% | 475 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $4,000 | 0.0% | 475 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $4,000 | -20.0% | 475 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $5,000 | -28.6% | 475 | 0.0% | 0.00% | -50.0% |
| Q2 2020 | $7,000 | +75.0% | 475 | 0.0% | 0.00% | +100.0% |
| Q1 2020 | $4,000 | -50.0% | 475 | 0.0% | 0.00% | -50.0% |
| Q4 2019 | $8,000 | -11.1% | 475 | 0.0% | 0.00% | -33.3% |
| Q3 2019 | $9,000 | -18.2% | 475 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $11,000 | +10.0% | 475 | 0.0% | 0.00% | -25.0% |
| Q1 2019 | $10,000 | +100.0% | 475 | 0.0% | 0.00% | +100.0% |
| Q4 2018 | $5,000 | -54.5% | 475 | 0.0% | 0.00% | -50.0% |
| Q3 2018 | $11,000 | 0.0% | 475 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $11,000 | 0.0% | 475 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $11,000 | – | 475 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Birchview Capital, LP | 2,213,326 | $18,386,000 | 10.92% |
| ORACLE INVESTMENT MANAGEMENT INC | 3,776,121 | $31,417,000 | 4.70% |
| GRIFFIN ASSET MANAGEMENT, INC. | 1,358,644 | $11,304,000 | 1.44% |
| Selkirk Management LLC | 288,805 | $2,403,000 | 0.72% |
| Chicago Capital, LLC | 1,593,126 | $13,255,000 | 0.56% |
| Cannell & Co. | 1,097,419 | $9,131,000 | 0.29% |
| TCI Wealth Advisors, Inc. | 55,586 | $462,000 | 0.20% |
| Belpointe Asset Management LLC | 197,853 | $1,646,000 | 0.14% |
| ALGERT GLOBAL LLC | 29,580 | $246,000 | 0.08% |
| THOMPSON INVESTMENT MANAGEMENT, INC. | 60,900 | $507,000 | 0.08% |